EUR J CANCER 润色咨询

EUROPEAN JOURNAL OF CANCER

出版年份:1990 年文章数:4798 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:4.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2024-01-15 ms6000001244498457 来自北京

    偏重的研究方向:肿瘤;肿瘤免疫
    经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-07-28 ms7000000964395486 来自浙江省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤
    经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-02-15 ms5000000259255905 来自北京

    偏重的研究方向:肿瘤化疗
    经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-02-13 ms5000000259255905 来自北京

    偏重的研究方向:肿瘤临床研究
    经验分享:一个肝母细胞瘤的research,都两周了还是with editor

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-09-11 lieju2 来自上海

    9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-10-05 ms2000000001186103

    审稿速度:1.0
    偏重的研究方向:肿瘤
    经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg)

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-12-11 ms3000001872426513 来自河南省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤免疫
    经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-02-19 1e1d9025m73(暂无匿称) 来自浙江省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;临床
    经验分享:投稿1个多月了,还是under review, 心理焦急

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向:肿瘤;肿瘤免疫<br>经验分享:with editor 2周,进入decsion in process流程,是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿2天后with editor,26天后decision in prosess,大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向:肿瘤化疗<br>经验分享:当天with editor,两周多后直接Decision in Process,感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向:肿瘤临床研究<br>经验分享:一个肝母细胞瘤的research,都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿, 9月8日 w i t h e d i t o r,当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆 (伤心流泪猫猫头.jpg), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤免疫<br>经验分享:写了一篇研究性质的letter,1000字左右,投稿后两天直接接收,只能用两个字形容:效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床<br>经验分享:投稿1个多月了,还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:癌症;肿瘤;临床<br>经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-20 一只虫虫

    审稿速度:4.0 | 投稿命中率:25.0
    偏重的研究方向:癌症;肿瘤;临床
    经验分享:做的自己的测序数据➕公共数据库的分析, Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20,一周了还在编辑手里,急死了,(¬_¬)后续进展会在评论里持续更新

    6

    展开6条回复
共156条页码: 1/16页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分